Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001453687-25-000099
Filing Date
2025-08-07
Accepted
2025-08-07 07:08:20
Documents
100
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rnac-20250630.htm   iXBRL 10-Q 1467450
2 EX-10.1 exhibit101fourthleaseamend.htm EX-10.1 40311
3 EX-31.1 exhibit311_6302025.htm EX-31.1 10399
4 EX-31.2 exhibit312_6302025.htm EX-31.2 10341
5 EX-32.1 exhibit321_6302025.htm EX-32.1 9932
  Complete submission text file 0001453687-25-000099.txt   8633452

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20250630.xsd EX-101.SCH 71920
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnac-20250630_cal.xml EX-101.CAL 69161
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnac-20250630_def.xml EX-101.DEF 386956
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20250630_lab.xml EX-101.LAB 782173
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20250630_pre.xml EX-101.PRE 601207
103 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20250630_htm.xml XML 1131621
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37798 | Film No.: 251191549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)